We've updated our Privacy Policy to make it clearer how we use your personal data.
We use cookies to provide you with a better experience, read our Cookie Policy
EP38636
Abstract: In dry powder inhalation (DPI), the fastest growing and most important form of inhalation therapy, the effectiveness of the drug absolutely depends on the excipients used to carry it. Larger excipient particles release much smaller active ingredient particles into the patient's lungs, while they themselves deposit harmlessly on the throat.Summary: The dry powder inhalant carrier is used to aid the deposition of the drug's active ingredient in the lungs and acts as a diluent to quantify the drug.References: https://www.formulationbio.com/products/dry-powder-inhalation-excipients.html
Ask the author a question about this poster.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Related Posters
Development of QSP model of COVID-19 based on Immune Response Template
Veronika Musatova, Oleg Demin, Maria Kupriyanova, Anna Viktorenko
Active Pharmaceutical Ingredient Analysis
Tylor
Penetration Enhancer Excipients
Helen Smith
PBPK modeling of T cell distribution in cancer patients
Dmitry Shchelokov 1, Oleg Demin Jr 1, Sara Brett 2 , Stefan Zajic 3, Lourdes Cucurull-Sanchez 2
Investigation of inflammation during Alzheimer's disease by quantitative systems pharmacology model
Andrey Masliukov, Tatiana Karelina
